Nadunolimab in Combination With Gemcitabine Plus Carboplatin in Patients With Advanced Triple Negative Breast Cancer.
Clinical trial NCT05181462 · COMPLETED
Trial details
- NCT number
- NCT05181462
- Sponsor
- Cantargia AB
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-11
- Primary completion
- 2026-04-09
- Enrollment
- 117
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.